Who must sign the report?

Typically the principal investigator and an authorized institutional official sign to attest to methods and compliance; additional signatures may be required by sponsors or regulators.

Can the report be signed electronically?

Yes. Electronic signatures that meet ESIGN (15 U.S.C. ch. 96) and state UETA standards are generally acceptable unless a specific statute requires a notarized wet signature.

Is notarization ever required?

Not generally for validation reports; notarization is needed only when a statute, contract, or institutional policy explicitly requires a notarized attestation.

What retention period applies?

Follow federal and industry minima: IRS three years (IRC §6501(a)), HIPAA six years (45 CFR §164.530(j)), and longer state-specific periods where applicable.

How do I prove an eSignature is valid?

Maintain an audit trail showing signer intent, authentication, IP/timestamp, and document versioning to satisfy the ESIGN four‑prong test for legal validity.

What if data need correction after signing?

Issue a revised version with a new version number, effective date, and signatures; retain the original with a clear amendment history for audit purposes.

Electronic Signature
Templates
Miscellaneous
Research Validation Study Report

Research Validation Study Report

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH VALIDATION STUDY REPORT

Study Identification

Study Title Study ID / Reference

Principal Investigator / Responsible Party

Organization

Contact Email

Contact Phone

Study Start Date: Anticipated Completion Date:

WHEREAS (Recitals)

WHEREAS, Client Name: has commissioned or requested validation of the methods, instruments, or processes described in this report; and

WHEREAS, Provider Name: has conducted the validation activities pursuant to the agreed scope and will report findings, performance metrics, and conclusions herein; and

WHEREAS, the Parties require a documented validation study report setting forth methods, results, and any limitations to support regulatory, quality, or business decisions.

Scope of Work

The Provider certifies that the following activities were performed as part of the validation study. Describe tests performed, instruments used, sample populations, and acceptance criteria in the field below.

Methodology and Validation Metrics

Sample size evaluated: Population description:

Primary Methods Summary

Sensitivity (%)

Specificity (%)

Overall Accuracy (%)

Results Summary

Conclusions and Recommendations

Limitations

Attachments and Supporting Materials

The following supporting documents are attached or available on request (check as applicable):

Raw data sets Statistical analysis outputs Study protocol Ethics / approvals

Payment Terms

Total Fee for validation study: $. Payment shall be made in accordance with the schedule set forth below.

Payment Schedule / Milestones

Late payment shall incur a late fee of % per month on outstanding amounts and reasonable collection costs.

Term and Termination

Term Commencement Date: . Term Expiration Date: .

Either Party may terminate this engagement for material breach by the other Party if such breach is not cured within days after written notice. Provider may suspend work pending receipt of undisputed payments.

Confidentiality

Each Party shall maintain in confidence all non-public information disclosed in connection with this validation study and shall not disclose such information except to employees, contractors, or agents who have a need to know and are bound by substantially similar confidentiality obligations. Confidential information does not include information that (i) is or becomes public through no breach of this Agreement, (ii) is rightfully received from a third party without obligation of confidentiality, or (iii) is independently developed without use of the disclosing Party's confidential information.

Governing Law

This Report, and any agreement embodied or referenced herein, shall be governed by and construed in accordance with the laws of the jurisdiction of without regard to conflicts of law principles.

Entire Agreement

This Report, together with any executed engagement letter or statement of work referenced herein, constitutes the entire agreement between the Parties with respect to the subject matter and supersedes all prior and contemporaneous agreements and understandings, whether written or oral. Any amendment must be in writing and signed by authorized representatives of both Parties.

Certifications and Authorizations

The undersigned certify that, to the best of their knowledge, the results and statements contained in this Report are complete and accurate as of the date of signature, that any deviations or errors have been disclosed in this Report, and that the signatory is authorized to enter into this agreement on behalf of the Party identified.

Party A (Client):

Party A Printed Name:

By:

Date:

Party B (Provider):

Party B Printed Name:

By:

Date:

What the Research Validation Study Report Is and Who It Serves

The Research Validation Study Report documents methods, sample selection, data validation steps, and results for a validation study used to confirm a research instrument or analytic approach. It explains objectives, inclusion/exclusion criteria, validation metrics, statistical procedures, and limitations so reviewers can assess reproducibility and reliability. The report typically accompanies IRB submissions, grant deliverables, regulatory filings, or internal quality reviews and should enable an independent reader to understand how data were collected, processed, and validated without needing additional materials.

Why a Well‑Prepared Report Matters

A clear Research Validation Study Report establishes reproducibility, supports ethical review, and documents that validation methods meet scientific and regulatory expectations.

Core Sections to Include in the Report

A professional Research Validation Study Report follows a consistent structure so readers can quickly locate methods, evidence, and conclusions.

Executive Summary

Concise objectives, primary validation outcomes, and a top-line statement of whether validation criteria were met; supports quick decision-making.

Study Design

Description of population, sampling approach, inclusion/exclusion criteria, and rationale for design choices to justify external validity.

Data Collection

Instruments used, data sources, collection dates, QA checks, and handling of missing or anomalous data for traceability.

Analytic Methods

Statistical tests, thresholds, software versions, and reproducible code references where applicable to permit independent verification.

Results and Metrics

Tabulated validation metrics (sensitivity, specificity, RMSE, interrater reliability, confidence intervals) with interpretation.

Limitations

Known biases, sample size constraints, and operational caveats that affect generalizability and future work recommendations.

Essential Information and Metadata to Record

Report Identifier: Unique ID and version number

Principal Investigator: Name and institutional affiliation

Study Dates: Start and end dates

Data Sources: Source systems and datasets

Validation Criteria: Pass/fail thresholds

Confidentiality Level: Public, internal, or restricted

Step‑by‑Step: Preparing the Report

Follow a consistent sequence to gather evidence, document methods, and finalize the Research Validation Study Report for review or filing.

01

Plan: Define objectives and validation criteria before data collection.
02

Collect: Capture raw data and QA logs with timestamps and provenance.
03

Analyze: Run validation analyses with recorded code and parameter settings.
04

Document: Assemble methods, results, limitations, and signatory approvals.

Customizing an Online Completion Workflow

Configure an eSubmission workflow to collect signatures, enforce required fields, and route the report for approvals.

Field	Configuration
Required Fields	Make key metadata mandatory
Signer Order	Set sequential or parallel routing
Authentication	Choose email, SMS code, or KBA
Audit Trail	Enable timestamp and IP capture

Where to File, Send, or Submit the Report

Identify the appropriate recipients and filing destinations based on the report's purpose, such as IRB, sponsor, regulatory agency, or internal archive.

Institutional Review Board: Submit to IRB for human subjects oversight when applicable
Grant Sponsor: Deliver to sponsor per contract requirements
Regulatory Agency: File with the relevant agency when required
Internal Records: Store in institutional repositories following retention rules

Digital Signing and eSubmission Requirements

Choose a platform that captures signer intent, consent, attribution, and preserves an auditable record for compliance with ESIGN and UETA.

Authentication: Email, SMS, or stronger methods
Audit Trail: IP, timestamp, and event log
Document Formats: PDF, DOCX, and flattened signed output

Ensure the chosen eSubmission method meets institutional policies and any industry mandates such as HIPAA for health data or 21 CFR Part 11 for FDA records.

Comparing eSignature Vendors for Report Execution

Vendor pricing and feature availability affect cost and compliance. The table lists typical starting prices and key capability differences relevant when collecting signatures and routing validation reports.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	No	No	Yes, limited	Yes, limited
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Typical Timelines and Processing Expectations

Set internal deadlines for draft completion, peer review, signatory approval, and final archiving to avoid delays in submission or audits.

Draft Completion:

Complete initial draft 30 days before submission

Peer Review:

Allow 7–14 days for technical review

Signatory Approval:

Allow 3–7 business days for signatures

Final Filing:

Submit per sponsor or agency deadlines

Record Archival:

Archive within 7 days after signing

Penalties and Risks from Inaccurate or Missing Reports

Regulatory Penalty: Fines or sanctions possible

Grant Noncompliance: Funding termination or repayment

Legal Exposure: Contract breaches and liability

Data Integrity Risk: Rejection due to unverifiable data

Audit Findings: Negative audit outcomes

Reputational Harm: Loss of stakeholder trust

Common Mistakes to Avoid When Preparing the Report

Missing metadata such as version or effective date causes confusion during review.
Unclear sampling descriptions that omit inclusion/exclusion criteria reduce reproducibility.
Absent or incomplete audit trails for data changes hinder validation and auditing.
Failing to record software versions and code blocks prevents independent verification.

Practical Tips for Accurate and Efficient Completion

Adopt standardized templates, enforce required fields, and capture audit trails to streamline review and reduce errors.

Use a Template

Start with a standard report template to ensure all sections are present and consistently ordered.

Lock Final Files

Lock signed PDFs to prevent post-signature edits; preserve source files for audit.

Record Provenance

Log data source, collection timestamps, and QC checks to support reproducibility.

Consistent Naming

Use a consistent filename convention including project, report type, and version.

Who Can Sign a Research Validation Study Report

Principal Investigator

The PI or delegated lead signs to attest to methodological accuracy and ethical compliance; signature typically includes printed name, title, and date.

Institutional Official

An authorized institutional signatory may be required for sponsor acceptance or contractual compliance and must identify their authority to sign.

Illustrative Use Cases

Real-world examples show how validation reports support oversight, funding, and regulatory compliance.

Clinical Validation Example

A hospital laboratory validated a diagnostic algorithm using retrospective data

achieved sensitivity above predefined threshold
the signed report supported IRB documentation and a subsequent FDA pre-submission discussion documenting methods and results.

Academic Study Example

A university team documented instrument reliability across multiple cohorts

reported interrater reliability metrics
the report accompanied a grant final deliverable and satisfied the sponsor's audit requirements.

Frequently Asked Questions about Research Validation Study Reports

Answers to common questions about scope, signatures, retention, and electronic submission for validation reports.

Need help? Contact support

Who must sign the report?
Typically the principal investigator and an authorized institutional official sign to attest to methods and compliance; additional signatures may be required by sponsors or regulators.
Can the report be signed electronically?
Yes. Electronic signatures that meet ESIGN (15 U.S.C. ch. 96) and state UETA standards are generally acceptable unless a specific statute requires a notarized wet signature.
Is notarization ever required?
Not generally for validation reports; notarization is needed only when a statute, contract, or institutional policy explicitly requires a notarized attestation.
What retention period applies?
Follow federal and industry minima: IRS three years (IRC §6501(a)), HIPAA six years (45 CFR §164.530(j)), and longer state-specific periods where applicable.
How do I prove an eSignature is valid?
Maintain an audit trail showing signer intent, authentication, IP/timestamp, and document versioning to satisfy the ESIGN four‑prong test for legal validity.
What if data need correction after signing?
Issue a revised version with a new version number, effective date, and signatures; retain the original with a clear amendment history for audit purposes.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now